Associations of polymorphisms in non-HLA loci with autoantibodies at the diagnosis of type 1 diabetes: INS and IKZF4 associate with insulin autoantibodies

Pediatric Diabetes

Volumn 14, Issue 7, 2013, Pages 490-496

  Lempainen, J ^a,b   Harkonen T ^c   Laine, Ap ^a   Knip, M ^d,e   Ilonen, J ^a,f   Groop, Per Henrik ^d   Lappi, Anneli ^c   Otonkoski, Timo ^c   Saha, Marja Terttu ^e   Simell, Olli ^b   Talvitie, Timo ^g   Vaarala, Outi ^h   Veijola, Riitta ⁱ   Aito, Henrikka ^j   Bondestam, Jonas ^k   Dahllund, Thomas ^l   Granvik, Johanna ^m   Haapalehto Ikonen, Maarit ⁿ   Hämäläinen, Anu Maaria ^o   Huopio, Hanna ^p   Johansson, Christian ^q   Kinnala, Anne ^r   Korhonen, Jussi ^s   Korteniemi, Maarit ^t   Lautala, Pentti ^u   Lindström, Kaija ^v   Miettinen, Päivi ^c   Mustila, Taina ^w   Nuuja, Anja ^x   Nykänen, Päivi ^y   Ojanperä, Jussi ^z   Laurila, Anne Putto ^b   Sankila, Juhani ^aa   Suomi, Anne Maarit ^g   Tenhola, Sirpa ^ab   Varimo, Pentti ^ac   Virransalo, Ritva ^ad   Vuolukka, Pentti ^ae   Vuorela, Niina ^af   Ylitalo, Samuli ^ag   more..

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

^d FOLKHÄLSAN RESEARCH CENTER   (Finland)

^e TAMPERE UNIVERSITY HOSPITAL   (Finland)

^f UNIVERSITY OF EASTERN FINLAND   (Finland)

^g SOUTH OSTROBOTHNIA CENTRAL HOSPITAL   (Finland)

^h NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

ⁱ OULU UNIVERSITY HOSPITAL   (Finland)

^j Porvoo Hospital   (Finland)

^k Lohja Hospital   (Finland)

^l Vastra Nyland Hospital   (Finland)

^m Jakobstad Hospital   (Finland)

ⁿ Rauma Hospital   (Finland)

^o JORVI HOSPITAL   (Finland)

^p KUOPIO UNIVERSITY HOSPITAL   (Finland)

^q Aland Central Hospital   (Finland)

^r Department of Pediatrics   (Finland)

^s NORTH KARELIA CENTRAL HOSPITAL   (Finland)

^t LAPLAND CENTRAL HOSPITAL   (Finland)

^u PÄIJÄT HÄME CENTRAL HOSPITAL   (Finland)

^v HYVINKÄÄ HOSPITAL   (Finland)

^w VAASA CENTRAL HOSPITAL   (Finland)

^x Central Hospital of Central   (Finland)

^y MIKKELI CENTRAL HOSPITAL   (Finland)

^z Central Ostrobothnia Central Hospital   (Finland)

^aa Savonlinna Central Hospital   (Finland)

^ab KYMENLAAKSO CENTRAL HOSPITAL   (Finland)

^ac KAINUU CENTRAL HOSPITAL   (Finland)

^ad SOUTH KARELIA CENTRAL HOSPITAL   (Finland)

^ae Länsi Pohja Central Hospital   (Finland)

^af KANTA HÄME CENTRAL HOSPITAL   (Finland)

^ag SATAKUNTA CENTRAL HOSPITAL   (Finland)

more..

Author keywords

IKZF4; INS; Insulin autoantibodies; Single nucleotide polymorphism; Type 1 diabetes

Indexed keywords

GLUTAMATE DECARBOXYLASE; HLA ANTIGEN; INSULIN ANTIBODY; PANCREAS ISLET CELL ANTIBODY; ZINC TRANSPORTER;

ADOLESCENT; ALLELE; ARTICLE; AUTOIMMUNITY; CHILD; CHILDHOOD DISEASE; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

IKZF4; INS; INSULIN AUTOANTIBODIES; SINGLE NUCLEOTIDE POLYMORPHISM; TYPE 1 DIABETES;

ADOLESCENT; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; IKAROS TRANSCRIPTION FACTOR; INFANT; INSULIN ANTIBODIES; ISLETS OF LANGERHANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84886641385     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/pedi.12046     Document Type: Article

References (33)

1. Verge CF, Gianani R, Kawasaki E et al. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 1996: 45: 926-933.
2. Kulmala P, Savola K, Petersen JS et al. Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. The Childhood Diabetes in Finland Study Group. J Clin Invest 1998: 101: 327-336.
3. Ziegler AG, Hummel M, Schenker M, Bonifacio E. Autoantibodyappearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes 1999: 199: 460-468.
4. Knip M, Korhonen S, Kulmala P et al. Prediction of type 1 diabetes in the general population. Diabetes Care 2010: 33: 1206-1212.
5. Bingley PJ, Bonifacio E, Williams AJ, Genovese S, Bottazzo GF, Gale EA. Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes 1997: 46: 1701-1710.
6. LaGasse JM, Brantley MS, Leech NJ et al. Successful prospective prediction of type 1 diabetes in schoolchildren through multiple defined autoantibodies: an 8-year follow-up of the Washington State Diabetes Prediction Study. Diabetes Care 2002: 25: 505-511.
7. Savola K, Sabbah E, Kulmala P, VÄhÄsalo P, Ilonen J, Knip M. Autoantibodies associated with Type I diabetes mellitus persist after diagnosis in children. Diabetologia 1998: 41: 1293-1297.
8. van Belle TL, Coppieters KT, von Herrath MG. Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol Rev 2011: 91: 79-118.
9. Komulainen J, Knip M, Sabbah E et al. Autoimmune and clinical characteristics of type I diabetes in children with different genetic risk loads defined by HLA-DQB1 alleles. Childhood Diabetes in Finland Study Group. Clin Sci (Lond) 1998: 94: 263-269.
10. MÄkinen A, HÄrkonen T, Ilonen J, Knip M. Characterization of the humoral immune response to islet antigen 2 in children with newly diagnosed type 1 diabetes. Eur J Endocrinol 2008: 159: 19-26.
11. Gullstrand C, Wahlberg J, Ilonen J, Vaarala O, Ludvigsson J. Progression to type 1 diabetes and autoantibody positivity in relation to HLA-risk genotypes in children participating in the ABIS study. Pediatr Diabetes 2008: 9: 182-190.
12. Williams AJ, Aitken RJ, Chandler MA, Gillespie KM, Lampasona V, Bingley PJ. Autoantibodies to islet antigen-2 are associated with HLA-DRB1*07 and DRB1*09 haplotypes as well as DRB1*04 at onset of type 1 diabetes: the possible role of HLA-DQA in autoimmunity to IA-2. Diabetologia 2008: 51: 1444-1448.
13. Ziegler AG, Standl E, Albert E, Mehnert H. HLA-associated insulin autoantibody formation in newly diagnosed type I diabetic patients. Diabetes 1991: 1991: 1146-1149.
14. Vandewalle CL, Falorni A, Lernmark A et al. Associations of GAD65- and IA-2- autoantibodies with genetic risk markers in new-onset IDDM patients and their siblings. The Belgian Diabetes Registry. Diabetes Care 1997: 20: 1547-1552.
15. Graham J, Hagopian WA, Kockum I et al. Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes. Diabetes 2002: 51: 1346-1355.
16. Plagnol V, Howson JM, Smyth DJ et al. Genome-wide association analysis of autoantibody positivity in type 1 diabetes cases. PLoS Genet 2011: 7: e1002216.
17. Maziarz M, Janer M, Roach JC et al. The association between the PTPN22 1858C>T variant and type 1 diabetes depends on HLA risk and GAD65 autoantibodies. Genes Immun 2010: 11: 406-415.
18. Hermann R, Knip M, Veijola R et al. Temporal changes in the frequencies of HLA genotypes in patients with Type 1 diabetes-indication of an increased environmental pressure? Diabetologia 2003: 46: 420-425.
19. Siljander HT, Simell S, Hekkala A et al. Predictive characteristics of diabetes-associated autoantibodies among children with HLA-conferred disease susceptibility in the general population. Diabetes 2009: 58: 2835-2842.
20. Benjamini E, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 1995: 57: 289-300.
21. Sarugeri E, Dozio N, Belloni C, Meschi F, Pastore MR, Bonifacio E. Autoimmune responses to the beta cell autoantigen, insulin, and the INS VNTR-IDDM2 locus. Clin Exp Immunol 1998: 114: 370-376.
22. Perez de Nanclares G, Bilbao JR, Castano L. No association of INS-VNTR genotype and IAA autoantibodies. Ann N Y Acad Sci 2004: 1037: 127-130.
23. Rajasalu T, Haller K, Salur L et al. Insulin VNTR I/III genotype is associated with autoantibodies against glutamic acid decarboxylase in newly diagnosed type 1 diabetes. Diabetes Metab Res Rev 2007: 23: 567-571.
24. Hermann R, Laine AP, Veijola R et al. The effect of HLA class II, insulin and CTLA4 gene regions on the development of humoral beta cell autoimmunity. Diabetologia 2005: 48: 1766-1775.
25. Walter M, Albert E, Conrad M et al. IDDM2/insulin VNTR modifies risk conferred by IDDM1/HLA for development of Type 1 diabetes and associated autoimmunity. Diabetologia 2003: 46: 712-720.
26. Vafiadis P, Bennett ST, Todd JA et al. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet 1997: 15: 289-292.
27. Pugliese A. Central and peripheral autoantigen presentation in immune tolerance. Immunology 2004: 111: 138-146.
28. Pugliese A, Zeller M, Fernandez A et al. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet 1997: 15: 293-297.
29. Wellcome Trust Case Control Consortium. Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature 2007: 447: 661-678.
30. Todd JA, Walker NM, Cooper JD et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 2007: 2007: 857-864.
31. Espino-Paisan L, de la Calle H, Fernandez-Arquero M et al. Polymorphisms in chromosome region 12q13 and their influence on age at onset of type 1 diabetes. Diabetologia 2011: 54: 2033-2037.
32. Keene KL, Quinlan AR, Hou X et al. Evidence for two independent associations with type 1 diabetes at the 12q13 locus. Genes Immun 2012: 13: 66-70.
33. Pan F, Yu H, Dang EV et al. Eos mediates Foxp3-dependent gene silencing in CD4+ regulatory T cells. Science 2009: 325: 1142- 1146.